News & Publications

Direct-to-patient clinical trials are removing traditional barriers to research participation by bringing study activities into patients’ homes. Through partnerships that combine virtual site operations with global medication delivery, trials can now reach more diverse populations while reducing travel burdens and accelerating enrollment. Read on to learn how Science 37 and Catalent are making this possible.

Cognizant, in collaboration with research KOLs from Australia, delves into the impact of Teletrials in Australia and how these hybrid, decentralized model of trials are bringing novel therapies closer to regional, rural and remote Australians. Teletrials promise to be a global case study on how public health can be promoted at a national level. Download this insightful publication and learn about the steps being taken by Australian Teletrial Program (ATP) to promote teletrials, point of view from Cognizant on how intelligent tech and process alignment can further enhance efficacy of teletrials and real world use cases of teletrials.

With 80% of trials failing to recruit enough patients and an explosion of recruitment vendors, how do you choose the right partner? This framework breaks down the landscape, from creative agencies to AI-driven technology, and reveals why success depends on understanding patient motivation, not just operations. Read on to discover how to select strategies that build trust and remove barriers.

Sites juggle multiple studies and endless questions, but the clear guidance they need often lags behind. Explore why timely answers and stronger communication are essential to keeping trials running smoothly.

Sales in clinical research isn’t about convincing, it’s about connecting. The most successful organizations don’t have bigger sales teams; they have cultures where everyone contributes to growth. What does it mean when your entire team becomes your “hidden sales force”? Read on to discover why the best organizations don’t sell harder — they lead better.

Site operations costs are escalating, but AI offers an unprecedented opportunity to transform financial management in clinical research. From faster budget negotiations to automated reconciliation, AI can address the pain points that burden sites and sponsors. Read on to discover how this technology revolution is reshaping the financial landscape of clinical trials.

October 13, 2025 – The Society for Clinical Research Sites (SCRS) proudly announces the 2025 recipients of the prestigious SCRS Eagle Award: Merck (known as MSD outside […]

October 9, 2025 – Mohammad Millwala, Founder and CEO of DM Clinical Research, has been recognized with the Christine K. Pierre Site Impact Award at the […]

The FDA has lifted REMS requirements for all approved CAR-T therapies, a move that could transform access for patients and research sites alike. What does this mean for trial participation, site activation, and the future of cell and gene therapy? Read on to see how this shift reshapes the CAR-T landscape.

Data entry continues to be one of the biggest sources of burden for sites. Electronic Health Record (EHR) to Electronic Data Capture (EDC) data transfer technology is a leading example of how sponsors, sites, and vendors are collaborating as an ecosystem to reduce the data entry bottleneck in clinical trial operations.

Improving the patient experience in clinical trials starts with supporting sites. Learn why Sponsors must prioritize the site experience to deliver better outcomes for patients and better results for the study.

July 22, 2025 – The Society for Clinical Research Sites (SCRS) is proud to announce Monroe Biomedical Research (MBR) as a new Global Impact Partner (GIP). […]

Participant compensation is a critical factor in clinical trials, directly influencing trust, retention, and overall study success. Explore approaches that adapt to diverse needs, enhance experiences, and reduce operational strain, ensuring trials run efficiently while maintaining credibility and participant satisfaction.

Clinical research is no easy feat — balancing science, regulations, operations, and people is a high-stakes challenge. At the center of it all is the protocol, our guiding document. But more often than not, translating that protocol into real-world action feels like decoding a Rosetta Stone.

After reviewing more than 1,250 protocols, ProofPilot’s Senior Clinical Program Manager, Kathryn Gentz, has identified six common mistakes that lead to confusion, deviations, and unnecessary costs. Here’s what to watch out for.

Behind every successful clinical trial is a site coordinator juggling chaos: patient care, payment issues, shifting schedules, and siloed systems — all while trying to maintain trust.

Read Emma’s story and see how Mural Health is reimagining site support by reducing admin overload, improving communication, and making participant management actually easier. Because when sites feel supported, trials succeed.